Barr Kelli L, Schwarz Erika R, Prakoso Dhani, Imtiaz Kehkashan, Pu Ruiyu, Morris Jr J Glenn, Khan Erum, Long Maureen T
Department of Biology, Baylor University, Waco, TX 76798, USA.
Department of Comparative Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608, USA.
Trop Med Infect Dis. 2020 Mar 3;5(1):38. doi: 10.3390/tropicalmed5010038.
Zika virus (ZIKV) circulates as two separate lineages, with significant genetic variability between strains. Strain-dependent activity has been reported for dengue virus, herpes simplex virus and influenza. Strain-dependent activity of subject specimens to a virus could be an impediment to serological diagnosis and vaccine development. In order to determine whether ZIKV exhibits strain-dependent activity when exposed to antibodies, we measured the neutralizing properties of polyclonal serum and three monoclonal antibodies (ZKA185, 753(3)C10, and 4G2) against three strains of ZIKV (MR-766, PRVABC59, and R103454). Here, MR-766 was inhibited almost 60% less by ZKA185 than PRVABC59 and R103454 ( = 0.008). ZKA185 enhanced dengue 4 infection up to 50% ( = 0.0058). PRVABC59 was not inhibited by mAb 753(3)C10 while MR-766 and R103453 were inhibited up to 90% ( = 0.04 and 0.036, respectively). Patient serum, regardless of exposure history, neutralized MR-766 ~30%-40% better than PRVABC56 or R103454 ( = 0.005-0.00007). The most troubling finding was the significant neutralization of MR-766 by patients with no ZIKV exposure. We also evaluated ZIKV antibody cross reactivity with various flaviviruses and found that more patients developed cross-reactive antibodies to Japanese encephalitis virus than the dengue viruses. The data here show that serological diagnosis of ZIKV is complicated and that qualitative neutralization assays cannot discriminate between flaviviruses.
寨卡病毒(ZIKV)以两个独立的谱系传播,毒株之间存在显著的基因变异性。登革病毒、单纯疱疹病毒和流感病毒都有毒株依赖性活性的报道。受试者标本对病毒的毒株依赖性活性可能会阻碍血清学诊断和疫苗开发。为了确定ZIKV在暴露于抗体时是否表现出毒株依赖性活性,我们测量了多克隆血清和三种单克隆抗体(ZKA185、753(3)C10和4G2)对三种ZIKV毒株(MR-766、PRVABC59和R103454)的中和特性。在此,ZKA185对MR-766的抑制作用比PRVABC59和R103454少近60%(P = 0.008)。ZKA185使登革热4型感染增强了50%(P = 0.0058)。PRVABC59未被单克隆抗体753(3)C10抑制,而MR-766和R-103453被抑制高达90%(分别为P = 0.04和0.036)。无论暴露史如何,患者血清对MR-766的中和作用比对PRVABC56或R103454好约30%-40%(P = 0.005-0.00007)。最令人不安的发现是未接触过ZIKV的患者对MR-766有显著的中和作用。我们还评估了ZIKV抗体与各种黄病毒的交叉反应性,发现与登革病毒相比,更多患者产生了针对日本脑炎病毒的交叉反应性抗体。此处的数据表明,ZIKV的血清学诊断很复杂,定性中和试验无法区分黄病毒。